title: Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.
abstract: To estimate the genotoxic risk of occupational exposure to antineoplastic drugs, chromosomal aberration (CAs) frequencies in peripheral lymphocytes were determined for 20 nurses handling antineoplastics and 18 referents matched for age and sex. Urinary cyclophosphamide (CP) excretion rates, which are used as a marker for drug handling, were also measured on these nurses. We have observed significant frequencies of CAs (about 2.5-fold increase) including chromatid breaks, gaps, and acentric fragments for nurses handling antineoplastics as compared to control subjects (p < 0.05, p < 0.01, excluding and including gaps, respectively). The mean value of CP excretion rate for 12 nurses was 1.63 microg/24 h, suggesting that when the nurses handled CP (and other antineoplastic drugs) this particular compound was absorbed. Our study has shown that increased genetic damage was evident in nurses, at population level, due to occupational exposure to antineoplastics. Until the effects of handling antineoplastics from low-level exposure are known, it will be important to keep the exposure to a minimum.
authors.affiliation: Department of Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey. sburgaz@farma.net.tr
authors.forename: S
authors.initials: S
authors.lastname: Burgaz
authors.forename: B
authors.initials: B
authors.lastname: Karahalil
authors.forename: Z
authors.initials: Z
authors.lastname: Canhi
authors.forename: F
authors.initials: F
authors.lastname: Terzioglu
authors.forename: G
authors.initials: G
authors.lastname: Ançel
authors.forename: R B M
authors.initials: RB
authors.lastname: Anzion
authors.forename: R P
authors.initials: RP
authors.lastname: Bos
authors.forename: E
authors.initials: E
authors.lastname: Hüttner
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002869:Chromosome Aberrations / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000652:urine; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009726:Nurses / Q000706:statistics & numerical data*; D016273:Occupational Exposure / Q000009:adverse effects* / Q000032:analysis
chemical_list: D000970:Antineoplastic Agents; D003520:Cyclophosphamide